Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dmitry Genkin(14.0%),CLS Therapeutics Ltd.(9.6%), etc.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated